103 related articles for article (PubMed ID: 7631066)
1. Visualization of dopamine nerve terminals in monkey by positron emission tomography using 4-[18F]fluoro-L-m-tyrosine.
Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Hirato M; Shibasaki T; Ohye C
Stereotact Funct Neurosurg; 1994; 62(1-4):191-6. PubMed ID: 7631066
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
DeJesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
J Nucl Med; 1997 Apr; 38(4):630-6. PubMed ID: 9098215
[TBL] [Abstract][Full Text] [Related]
3. A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
Nahmias C; Wahl L; Chirakal R; Firnau G; Garnett ES
Mov Disord; 1995 May; 10(3):298-304. PubMed ID: 7651447
[TBL] [Abstract][Full Text] [Related]
4. 4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography.
Melega WP; Perlmutter MM; Luxen A; Nissenson CH; Grafton ST; Huang SC; Phelps ME; Barrio JR
J Neurochem; 1989 Jul; 53(1):311-4. PubMed ID: 2786055
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
[TBL] [Abstract][Full Text] [Related]
7. Visualization of dopamine nerve terminals by positron tomography using [18F]fluoro-beta-fluoromethylene-m-tyrosine.
DeJesus OT; Holden JE; Endres C; Murali D; Oakes TR; Shelton S; Uno H; Houser D; Freund L; Perlman SB
Brain Res; 1992 Nov; 597(1):151-4. PubMed ID: 1477728
[TBL] [Abstract][Full Text] [Related]
8. 6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.
Jordan S; Eberling JL; Bankiewicz KS; Rosenberg D; Coxson PG; VanBrocklin HF; O'Neil JP; Emborg ME; Jagust WJ
Brain Res; 1997 Mar; 750(1-2):264-76. PubMed ID: 9098552
[TBL] [Abstract][Full Text] [Related]
9. The time course of metabolites in human plasma after 6-[(18)F]fluoro-l-m-tyrosine administration.
Wahl LM; Chen JJ; Thompson M; Chirakal R; Nahmias C
Eur J Nucl Med; 1999 Nov; 26(11):1407-12. PubMed ID: 10552081
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Shibasaki T; Ohye C
Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583
[TBL] [Abstract][Full Text] [Related]
11. Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.
Brown WD; DeJesus OT; Pyzalski RW; Malischke L; Roberts AD; Shelton SE; Uno H; Houser WD; Nickles RJ; Holden JE
Synapse; 1999 Nov; 34(2):111-23. PubMed ID: 10502310
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
Dejesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
Synapse; 2001 Jan; 39(1):58-63. PubMed ID: 11071710
[TBL] [Abstract][Full Text] [Related]
14. Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.
Barrio JR; Huang SC; Yu DC; Melega WP; Quintana J; Cherry SR; Jacobson A; Namavari M; Satyamurthy N; Phelps ME
J Cereb Blood Flow Metab; 1996 Jul; 16(4):667-78. PubMed ID: 8964807
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two methods for the analysis of [18F]6-fluoro-L-m-tyrosine PET data.
Eberling JL; Pivirotto P; Bringas J; Bankiewicz KS
Neuroimage; 2004 Sep; 23(1):358-63. PubMed ID: 15325383
[TBL] [Abstract][Full Text] [Related]
16. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
17. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
